Amgen – Amgen, Teva Ordered to Face Generic Delay Claims Over Sensipar
By dropping the patent case, “Amgen was allowing Teva to retain a minimum of a number of the” practically $400 million it “earned at Amgen's expense” through the …
Home » Amgen – Amgen, Teva Ordered to Face Generic Delay Claims Over Sensipar
Amgen – Amgen, Teva Ordered to Face Generic Delay Claims Over Sensipar
By dropping the patent case, “Amgen was allowing Teva to retain a minimum of a number of the” practically $400 million it “earned at Amgen's expense” through the …